Equities

Angle PLC

AGL:LSE

Angle PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)8.00
  • Today's Change0.25 / 3.23%
  • Shares traded266.47k
  • 1 Year change-35.90%
  • Beta1.0040
Data delayed at least 20 minutes, as of Nov 04 2024 15:07 GMT.
More ▼

Profile data is unavailable for this security.

About the company

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

  • Revenue in GBP (TTM)2.02m
  • Net income in GBP-18.03m
  • Incorporated2003
  • Employees150.00
  • Location
    Angle PLCThe Surrey Research Park, 10 Nugent RoadGUILDFORD GU2 7AFUnited KingdomGBR
  • Phone+44 14 8334 3434Fax+44 14 8368 5836
  • Websitehttps://www.angleplc.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Genedrive PLC272.00k-5.00m13.04m43.0013.04m43.00
Abingdon Health PLC6.14m-1.27m15.01m85.0015.01m85.00
Inspiration Healthcare Group PLC34.30m-9.76m15.47m224.0015.47m224.00
Belluscura PLC1.40m-14.39m17.22m35.0017.22m35.00
Polarean Imaging PLC1.45m-6.61m18.67m29.0018.67m29.00
Ondine Biomedical Inc906.17k-7.92m24.26m43.0024.26m43.00
ANGLE plc2.02m-18.03m25.00m150.0025.00m150.00
Renalytix PLC2.63m-35.76m26.63m80.0026.63m80.00
Data as of Nov 04 2024. Currency figures normalised to Angle PLC's reporting currency: UK Pound GBX

Institutional shareholders

21.74%Per cent of shares held by top holders
HolderShares% Held
Global Frontier Investments LLCas of 11 Jul 202422.09m6.85%
Hargreaves Lansdown Asset Management Ltd.as of 01 Aug 202410.60m3.29%
Baillie Gifford & Co.as of 23 Jun 20238.06m2.50%
Chelverton Asset Management Ltd.as of 31 Dec 20237.51m2.33%
Aegon Asset Management UK PLCas of 06 Jan 20245.30m1.64%
IG Markets Ltd.as of 01 Aug 20243.84m1.19%
Jarvis Investment Management Ltd.as of 01 Aug 20243.45m1.07%
Evelyn Partners Investment Management LLPas of 01 Aug 20243.32m1.03%
KW Investment Management Ltd.as of 01 Aug 20243.19m0.99%
Unicorn Asset Management Ltd.as of 01 Aug 20242.77m0.86%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.